These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 23316481)
1. Novel gain of function approaches for vaccine candidate identification in Burkholderia pseudomallei. Dowling AJ Front Cell Infect Microbiol; 2012; 2():139. PubMed ID: 23316481 [TBL] [Abstract][Full Text] [Related]
2. Reverse vaccinology and subtractive genomics-based putative vaccine targets identification for Burkholderia pseudomallei Bp1651. Hizbullah ; Nazir Z; Afridi SG; Shah M; Shams S; Khan A Microb Pathog; 2018 Dec; 125():219-229. PubMed ID: 30243554 [TBL] [Abstract][Full Text] [Related]
3. Melioidosis: where do we stand in the development of an effective vaccine? Muruato LA; Torres AG Future Microbiol; 2016; 11(4):477-80. PubMed ID: 27081770 [No Abstract] [Full Text] [Related]
4. Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed T Tapia D; Sanchez-Villamil JI; Stevenson HL; Torres AG mBio; 2021 Jun; 12(3):e0122721. PubMed ID: 34182777 [TBL] [Abstract][Full Text] [Related]
6. Identification of CD4+ T-cell epitope and investigation of HLA distribution for the immunogenic proteins of Burkholderia pseudomallei using in silico approaches - A key vaccine development strategy for melioidosis. Swetha RG; Sandhya M; Ramaiah S; Anbarasu A J Theor Biol; 2016 Jul; 400():11-8. PubMed ID: 27086038 [TBL] [Abstract][Full Text] [Related]
8. Combating the great mimicker: latest progress in the development of Khakhum N; Chapartegui-González I; Torres AG Expert Rev Vaccines; 2020 Jul; 19(7):653-660. PubMed ID: 32669008 [TBL] [Abstract][Full Text] [Related]
9. Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application. Lankelma JM; Wagemakers A; Birnie E; Haak BW; Trentelman JJA; Weehuizen TAF; Ersöz J; Roelofs JJTH; Hovius JW; Wiersinga WJ; Bins AD Virulence; 2017 Nov; 8(8):1683-1694. PubMed ID: 28323523 [TBL] [Abstract][Full Text] [Related]
10. Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials? Titball RW; Burtnick MN; Bancroft GJ; Brett P Vaccine; 2017 Oct; 35(44):5981-5989. PubMed ID: 28336210 [TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of clinical Burkholderia pseudomallei isolates from southwestern coastal region of India, using multi-locus sequence typing. Kamthan A; Shaw T; Mukhopadhyay C; Kumar S PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006915. PubMed ID: 30418974 [TBL] [Abstract][Full Text] [Related]
15. Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis. Casey WT; Spink N; Cia F; Collins C; Romano M; Berisio R; Bancroft GJ; McClean S Vaccine; 2016 May; 34(23):2616-21. PubMed ID: 27091689 [TBL] [Abstract][Full Text] [Related]
16. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Wiersinga WJ; van der Poll T; White NJ; Day NP; Peacock SJ Nat Rev Microbiol; 2006 Apr; 4(4):272-82. PubMed ID: 16541135 [TBL] [Abstract][Full Text] [Related]
17. Prediction of Burkholderia pseudomallei DsbA substrates identifies potential virulence factors and vaccine targets. Vezina B; Petit GA; Martin JL; Halili MA PLoS One; 2020; 15(11):e0241306. PubMed ID: 33216758 [TBL] [Abstract][Full Text] [Related]
18. Melioidosis: an important cause of pneumonia in residents of and travellers returned from endemic regions. Currie BJ Eur Respir J; 2003 Sep; 22(3):542-50. PubMed ID: 14516149 [TBL] [Abstract][Full Text] [Related]
19. Global and regional dissemination and evolution of Burkholderia pseudomallei. Chewapreecha C; Holden MT; Vehkala M; Välimäki N; Yang Z; Harris SR; Mather AE; Tuanyok A; De Smet B; Le Hello S; Bizet C; Mayo M; Wuthiekanun V; Limmathurotsakul D; Phetsouvanh R; Spratt BG; Corander J; Keim P; Dougan G; Dance DA; Currie BJ; Parkhill J; Peacock SJ Nat Microbiol; 2017 Jan; 2():16263. PubMed ID: 28112723 [TBL] [Abstract][Full Text] [Related]
20. Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model. Trevino SR; Dankmeyer JL; Fetterer DP; Klimko CP; Raymond JLW; Moreau AM; Soffler C; Waag DM; Worsham PL; Amemiya K; Ruiz SI; Cote CK; Krakauer T PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009125. PubMed ID: 33571211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]